Oaktree Acquisition Corp III Life Sciences

OACC

Börsenwert 263 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 AQR Arbitrage Greenwich, Connecticut	14,2 Mio. $	–	–	–
2	2 Fort Baker Capital Management Larkspur, California	11,8 Mio. $	+1,12 Mio. $	+105.394	+11 %
3	DAM 3 Decagon Asset Management London, United Kingdom	11,7 Mio. $	+946.785 $	+88.900	+9 %
4	4 Empyrean Capital Partners Los Angeles, California	9,6 Mio. $	–	–	–
5	5 D.E. Shaw & Co New York	9,23 Mio. $	–	–	–
6	6 Boussard & Gavaudan Gestion SAS Paris, France	7,7 Mio. $	+7,67 Mio. $	+720.000	Neu
7	LA 7 Linden Advisors New York	6,43 Mio. $	–	–	–
8	8 Toronto Dominion Bank Toronto, Ontario, Ontario, Canada	5,93 Mio. $	+613.909 $	+57.644	+12 %
9	9 Sculptor Capital New York	5,68 Mio. $	–	–	–
10	10 Goldman Sachs New York	5,67 Mio. $	–	–	–
11	11 Moore Capital Management New York	5,62 Mio. $	–	–	–
12	12 LMR Partners London, United Kingdom	5,47 Mio. $	–	–	–
13	13 Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada	5,36 Mio. $	–	–	–
14	14 Verition Fund Management Greenwich, Connecticut	5,04 Mio. $	+1,76 Mio. $	+165.294	+54 %
15	15 Ghisallo Capital Management Boston, Massachusetts	4,82 Mio. $	–	–	–
16	16 Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada	4,82 Mio. $	–	–	–
17	17 Two Sigma Investments New York	4,68 Mio. $	–	–	–
18	GAM 18 Gritstone Asset Management Bethesda, Maryland	4,23 Mio. $	–	–	–
19	19 Radcliffe Capital Management Bala Cynwyd, Pennsylvania	4,14 Mio. $	+50.875 $	+4.777	+1 %
20	KPF 20 K2 Principal Fund Toronto, Ontario, Canada	3,92 Mio. $	+1,82 Mio. $	+170.608	+87 %
21	21 Glazer Capital LLC New York	3,83 Mio. $	-2.907 $	-273	-0,1 %
22	22 Periscope Capital Toronto, Ontario, Canada	3,46 Mio. $	–	–	–
23	23 Hudson Bay Capital Management Stamford, Connecticut	3,21 Mio. $	–	–	–
24	24 O'Connor Alternative Investments New York	3,21 Mio. $	–	–	–
25	25 Governors Lane New York	3,21 Mio. $	–	–	–

Oaktree Acquisition Corp III Life Sciences OACC Börsenwert 263 Mio. $

Oaktree Acquisition Corp III Life Sciences

OACC

Börsenwert 263 Mio. $